SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BONDANELLI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.331
AS - Asia 5.350
EU - Europa 4.196
SA - Sud America 884
AF - Africa 96
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.868
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.076
SG - Singapore 2.306
CN - Cina 1.624
DE - Germania 1.436
BR - Brasile 762
UA - Ucraina 678
IT - Italia 639
HK - Hong Kong 525
RU - Federazione Russa 335
GB - Regno Unito 320
TR - Turchia 308
VN - Vietnam 254
FI - Finlandia 237
PL - Polonia 151
SE - Svezia 139
MX - Messico 118
CA - Canada 109
FR - Francia 90
IN - India 67
ID - Indonesia 53
AR - Argentina 46
ZA - Sudafrica 45
BD - Bangladesh 41
NL - Olanda 41
JP - Giappone 39
ES - Italia 30
EC - Ecuador 25
IQ - Iraq 25
BE - Belgio 23
PK - Pakistan 19
LT - Lituania 17
AT - Austria 15
MA - Marocco 13
VE - Venezuela 12
PY - Paraguay 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
MY - Malesia 8
SA - Arabia Saudita 8
TN - Tunisia 8
AU - Australia 7
CO - Colombia 7
CZ - Repubblica Ceca 7
IE - Irlanda 7
DZ - Algeria 6
KE - Kenya 6
PA - Panama 6
UY - Uruguay 6
BO - Bolivia 5
TH - Thailandia 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
KG - Kirghizistan 4
KR - Corea 4
LB - Libano 4
NP - Nepal 4
PS - Palestinian Territory 4
RO - Romania 4
TT - Trinidad e Tobago 4
AL - Albania 3
AZ - Azerbaigian 3
DK - Danimarca 3
ET - Etiopia 3
NG - Nigeria 3
NI - Nicaragua 3
PE - Perù 3
PH - Filippine 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
PT - Portogallo 1
Totale 19.857
Salva come PNG Salva come JPEG
Città #
Singapore 1.358
Ashburn 905
Woodbridge 905
Chandler 722
Jacksonville 675
Fairfield 604
Santa Clara 546
Beijing 541
Hong Kong 522
Houston 410
Ann Arbor 342
Wilmington 278
Seattle 219
Izmir 206
Nanjing 203
Addison 202
Cambridge 183
Munich 176
New York 173
Los Angeles 172
Princeton 155
Dallas 152
Warsaw 147
Milan 116
San Diego 94
Shanghai 85
Ho Chi Minh City 78
Mexico City 74
São Paulo 74
Shenyang 70
Boardman 66
Hanoi 64
Helsinki 64
Ferrara 61
Hebei 56
Hefei 55
Dearborn 50
Turku 47
Nanchang 46
Tianjin 44
London 40
Bremen 39
Montreal 39
Changsha 38
Buffalo 36
Chicago 36
Jakarta 35
Orem 33
Tokyo 33
Brooklyn 32
Denver 30
Jiaxing 30
Moscow 30
Phoenix 29
Poplar 28
Stockholm 28
Kunming 27
San Francisco 27
Toronto 26
Chennai 25
Falls Church 25
Washington 25
Jinan 24
Johannesburg 24
Redwood City 24
San Jose 24
Brussels 23
Mountain View 23
Rome 23
Boston 22
Rio de Janeiro 22
Atlanta 21
Norwalk 21
Bologna 19
Manchester 19
Belo Horizonte 18
Zhengzhou 18
Frankfurt am Main 17
Falkenstein 16
Guangzhou 16
Ankara 15
Ningbo 15
Brasília 14
Campinas 14
Council Bluffs 14
Curitiba 14
San Mateo 14
Haiphong 13
Modena 13
Auburn Hills 12
Augusta 12
Baghdad 12
Mumbai 12
Amsterdam 11
Orange 11
Querétaro 11
Hải Dương 10
Ottawa 10
Quito 10
Taizhou 10
Totale 12.252
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 285
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 224
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 219
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 207
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 201
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 198
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 191
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 189
Acromegaly is associated with increased cancer risk: a survey in Italy 183
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 179
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 176
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 176
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 174
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 174
Growth hormone excess promotes breast cancer chemoresistance 174
Antiproliferative effects of somatostatin analogs in pituitary adenomas 170
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 168
Diurnal rhythm of plasma catecholamines in acromegaly 167
Pituitary side effects of old and new drugs. 161
A new VHL polymorphism in a big family from Ferrara 160
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 159
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 158
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 157
In vitro testing of new somatostatin analogs on pituitary tumor cells 156
Role of the serotonergic system in the genesis of vasovagal syncope 155
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 155
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 155
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 155
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 154
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 154
Cerebral aneurysm and acromegaly: a case report 153
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 153
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 152
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 151
L’iperplasia surrenale congenita e la pubertà precoce 151
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study 150
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 150
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 148
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 148
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 147
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 146
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 146
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 144
Le alterazioni pressorie nell'acromegalia: fattori umorali 144
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 144
Functional hypothalamic and drug-induced amenorrhea: an overview 144
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 143
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 142
Delta opioid receptor involvement in endocrine pathophysiology 141
Glucose metabolism alterations in acromegaly 141
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 140
Cerebrovascular disease and GH-IGF-i axis function 138
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 137
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 137
ASSE GH-IGF-I NELL'INVECCHIAMENTO 136
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 135
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 134
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 133
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 133
Replacement therapy and quality of life improvement in adult GHD patients 132
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 131
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 130
null 130
Prevalence of hypopituitarismin patients with cerebrovascular diseases 128
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 127
Bone metastases frequency, distribution, clinical and imaging characteristics in neuroendocrine tumors: our experience 127
Human galanin reduces plasma norepinephrine levels in man 123
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 123
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 123
Sistema Simpatoadrenomidollare nei pazienti acromegalici 122
Systemic illness 121
RELIABILITY OF QUANTITATIVE ULTRASOUND IN THE FOLLOW-UP OF ADULTS WITH GH DEFICIENCY UNDERGOING REPLACEMENT THERAPY 121
INVECCHIAMENTO E GH 121
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 121
Efficay and safety of teriparatide treatment 120
Predictors of morbidity and mortality in acromegaly: An Italian survey 120
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 119
Occurrence of pituitary dysfunction following traumatic brain injury 118
null 118
Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy 118
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 117
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 117
Effects of pasireotide on bronchial carcinoids in primary culture 117
Successful treatment with everolimus of functioning liver metastases from a pancreatic insulinoma 117
FISIOPATOLOGIA, CLASSIFICAZIONE, PATOGENESI (ACROMEGALIA) 116
Role of GH-IGF-1 excess on periodontal tissues 116
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation. 116
Acromegaly in the elderly patients 116
null 114
null 113
Bariatric surgery in an obese patients with craniopharyngioma 113
IPOPITUITARISMO E TRAUMA CRANICO. 113
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 113
null 111
Tumori neuroendocrini: i meccanismi fisiopatologici 111
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 111
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation 110
Pathogenesis and prevalence of hypertension in acromegaly 110
Differential effects of deltorphin on arginine and galanin-induced growth hormone secretion in healthy man. 110
GH-IGF-I deficit 110
Totale 14.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.714
Totale 108.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021827 0 0 0 0 0 147 37 162 31 185 198 67
2021/20221.387 36 139 90 60 55 58 48 61 42 120 118 560
2022/20231.527 155 136 52 203 207 230 74 114 214 16 69 57
2023/2024834 68 95 50 25 51 176 25 79 25 24 24 192
2024/20253.452 99 76 267 106 419 359 129 131 579 428 483 376
2025/20265.356 939 384 800 1.162 1.615 456 0 0 0 0 0 0
Totale 20.055